Here are entered works on the process of observing, recording, or detecting the effects of a drug administered therapeutically or diagnostically to an individual. Works on the detection of adverse effects of medicines in the general population are entered under Pharmacovigilance.
Drugs, Nonprescription -- Labeling -- United States. / https://id.loc.gov/authorities/subjects/sh85039761 https://id.loc.gov/authorities/subjects/sh00006378 https://id.loc.gov/authorities/names/n78095330-781 : United States.
Drugs -- North America -- History -- 20th century. / https://id.loc.gov/authorities/subjects/sh85039719 https://id.loc.gov/authorities/subjects/sh85092455-781 https://id.loc.gov/authorities/subjects/sh2002006165 : Crellin, J. K.
Drugs of abuse -- Identification. / https://id.loc.gov/authorities/subjects/sh94005490 https://id.loc.gov/authorities/subjects/sh2002011456 : United Nations Office on Drugs and Crime.
Drugs of abuse -- Social aspects. / https://id.loc.gov/authorities/subjects/sh94005490 https://id.loc.gov/authorities/subjects/sh00002758 : Boothroyd, Dave,
2006
1
Drugs of abuse -- Standards. / https://id.loc.gov/authorities/subjects/sh94005490 https://id.loc.gov/authorities/subjects/sh00007508 : United Nations Office on Drugs and Crime.
Drugs of limited commercial value -- See Orphan drugs
Here are entered works on drugs which appear to be useful for the treatment of rare disorders, but have difficulty in finding a sponsor for development and marketing because of insufficient anticipated financial return.